MR Spectroscopy (MRS) can provide chemical composition of in vivo tissue non-invasively. Detection of signature chemical composition in tumors which are expected based on knowledge of histopathology could enable discrimination between tumor subtypes and grade by MRS. In this feasibility study we demonstrate ability to perform with success renal MRS in health volunteers mapping normal signature composition of renal tissue and provide a platform to expand the work to renal cancer tumor composition mapping and discrimination therewith based on metabolite content.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords